Solara Active Pharma Sciences Ltd. Financial Overview
Solara Active Pharma Sciences Ltd.'s market cap is currently ₹20.70B. The company's EPS TTM is ₹-2.271; its P/E ratio is 423.91; Solara Active Pharma Sciences Ltd. is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
